Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

A Long-term Follow-up Study of Subjects With Malignancies Treated With CRISPR CAR Cellular Therapies Recruiting

2024-512479-11-00 Solid Malignancy 9 2024-07-26
A long-term follow-up study for patients treated with Galapagos CAR T cell therapies Recruiting

2023-510173-34-00 Relapsed/refractory multiple myeloma 5 2024-07-26
A study comparing TAR-210 versus single agent treatment instilled directly into the bladder in people with bladder cancer with FGFR gene alt… Recruiting

2023-507684-19-00 FGFR+ Intermediate-risk Non-muscle Invasive Bladder Can 5 2024-07-24
PHASE IB/II CLINICAL TRIAL EVALUATING THE SAFETY AND EFFICACY OF CHEMOIMMUNOTHERAPY PLUS SHORT COURSE OF MEK INHIBITOR IN FIRST LINE OF TREA… Recruiting

2023-508477-87-00 Patients with localy advanced or metastatic non squamou 9 2024-07-24
A study to assess safety and efficacy of SOT201 in patients with advance/metastatic cancer Recruiting

2023-504330-21-00 advanced/metastatic solid tumors 1 2024-07-22
FFCD 2006 – NEORAF : A MULTI-CENTRE, OPEN-LABEL, PILOT TRIAL EVALUATING THE COMBINATION ENCORAFENIB AND CETUXIMAB IN A NEOADJUVANT SETTING I… Recruiting

2024-514107-34-00 BRAF V600E-MUTATED LOCALISED COLON OR UPPER RECTUM CANC 4 2024-07-18
Immunotherapy with dostarlimab for locally advanced or metastatic cancer (non-colorectal/non-endometrial) with tumor dMMR/MSI Recruiting

2023-505298-34-00 Patients with dMMR/MSI (non-colorectal/non-endometrial) 4 2024-07-18
A clinical study of MK-2870 and chemotherapy to treat lung cancer (MK-2870-009) Recruiting

2023-504910-31-00 Non-small Cell Lung Cancer (NSCLC) 5 2024-07-15
Phase 2 Study of HER3-DXd in Locally Advanced or Metastatic Solid Tumors Recruiting

2023-507641-29-00 Locally Advanced or Metastatic Solid Tumors 4 2024-07-15
Surgical treatment with or without apalutamide in subjects with high risk prostate cancer who are candidates for radical prostatectomy and s… Recruiting

2024-515049-41-00 metastatic prostate cancer 4 2024-07-12
Clinical trial of MK-2870 in combination with pembrolizumab in people who have had surgery to treat triple negative breast cancer Recruiting

2023-504962-52-00 Triple negative breast cancer. 5 2024-07-10
Dose Escalation and Dose Expansion Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Patients with Advanced … Recruiting

2023-508178-27-00 Participants with Advanced KRASG12C-Mutated Solid Tumor 9 2024-07-10
Phase I/II, open-label, multi-center study to evaluate the safety and efficacy of glyco-humanized polyclonal antibody directed against tumor… Recruiting

2023-509648-88-00 Peripheral T cells lymphoma (PTCL) 9 2024-07-09
Adjuvant therapy in high risk adrenocortical carcinoma (ADIUVO-2) Recruiting

2022-500013-32-01 Adrenocortical carcinoma 5 2024-07-05
Talazoparib plus Enzalutamide after progression to prior ARPi in Metastatic Prostate Cancer Recruiting

2023-510536-37-00 Prostate Cancer 4 2024-07-05
N-PLUS Recruiting

2022-502559-69-01 advanced (FIGO stage IIIA, IIIB, IIIC, or IV of the 201 4 2024-07-04
Pan-lesions SBRT combined with lymphocyte support through ATRA-driven blockade of MDSC in patients with oligometastatic solid cancer (LySATR… Recruiting

2022-500680-13-00 Oligometastatic solid cancer 9 2024-07-04
An International, Prospective, Open-label, Multi-center, Randomized Phase III Study comparing lutetium (177Lu) vipivotide tetraxetan (AAA617… Recruiting

2022-502956-29-00 Oligometastatic prostate cancer (OMPC) 5 2024-07-01
AVO-CLL: a phase III multicenter, randomized, open-label, clinical trial comparing efficacy and safety of acalabrutinib in combination with … Recruiting

2023-508423-13-00 Chronic lymphocytic leukemia 5 2024-07-01
An open-label, phase I/II study of T3P-Y058-739, a genetically-modified strain of the bacterium Yersinia enterocolitica, in patients with ad… Recruiting

2023-504199-19-00 Solid Tumours 7 2024-06-26
Study of INBRX-109 in Patients with Advanced Solid Tumors, Including Sarcomas. Recruiting

2023-508139-29-00 Advanced or metastatic solid tumors 7 2024-06-26
A trial to learn if AZD0305 alone and in combination with other cancer treatments is safe and works in adults with multiple myeloma Recruiting

2023-508590-89-00 Multiple Myeloma 7 2024-06-25
Personalized medicine for advanced biliary cancer patients Recruiting

2023-508100-38-00 Advanced Biliary Cancer (ABC) 5 2024-06-24
PERELI - A phase 2, open label study of PEmigatinib and REtifanlimab in advanced dedifferentiated Liposarcoma Recruiting

2022-501993-21-00 Dedifferentiated Liposarcoma 4 2024-06-20